Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: results from a large observational study

BACKGROUND: Postinjection delirium/sedation syndrome (PDSS) has been reported uncommonly during treatment with olanzapine long-acting injection (LAI), a sustained-release formulation of olanzapine. AIMS: The primary aim of the study was to estimate the incidence per injection and per patient of PDSS...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyers, Kristin J., Upadhyaya, Himanshu P., Landry, John L., Chhabra-Khanna, Rashna, Falk, Deborah M., Seetharama Rao, Balasubramanya, Jones, Meghan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal College of Psychiatrists 2017
Materias:
Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550823/
https://www.ncbi.nlm.nih.gov/pubmed/28811926
http://dx.doi.org/10.1192/bjpo.bp.116.004382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550823/
https://www.ncbi.nlm.nih.gov/pubmed/28811926
http://dx.doi.org/10.1192/bjpo.bp.116.004382

Ejemplares similares